The DOI matches its Crossref record; 53 of the 55 references it cites were found in a registry or an index.
The MTA at 8 Years: Prospective Follow-up of Children Treated for Combined-Type ADHD in a Multisite Study
Open accessAbstract
Objectives To determine any long-term effects, 6 and 8 years after childhood enrollment, of the randomly assigned 14-month treatments in the NIMH Collaborative Multisite Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder (MTA; N = 436); to test whether attention-deficit/hyperactivity disorder (ADHD) symptom trajectory through 3 years predicts outcome in subsequent years; and to examine functioning level of the MTA adolescents relative to their non-ADHD peers (local normative comparison group; N = 261).Method Mixed-effects regression models with planned contrasts at 6 and 8 years tested a wide range of symptom and impairment variables assessed by parent, teacher, and youth report.Results In nearly every analysis, the originally randomized treatment groups did not differ significantly on repeated measures or newly analyzed variables (e.g., grades earned in school, arrests, psychiatric hospitalizations, other clinically relevant outcomes). Medication use decreased by 62% after the 14-month controlled trial, but adjusting for this did not change the results. ADHD symptom trajectory in the first 3 years predicted 55% of the outcomes. The MTA participants fared worse than the local normative comparison group on 91% of the variables tested.Conclusions Type or intensity of 14 months of treatment for ADHD in childhood (at age 7.0-9.9 years) does not predict functioning 6 to 8 years later. Rather, early ADHD symptom trajectory regardless of treatment type is prognostic. This finding implies that children with behavioral and sociodemographic advantage, with the best response to any treatment, will have the best long-term prognosis. As a group, however, despite initial symptom improvement during treatment that is largely maintained after treatment, children with combined-type ADHD exhibit significant impairment in adolescence. Innovative treatment approaches targeting specific areas of adolescent impairment are needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Long-term follow-up studies suggest that hyperactive and impulsive behaviors tend to decrease with age, while inattentive symptoms show greater persistence and may stay life-long (Biederman et al., 2000; Molina et al., 2009).”
From A Review of Heterogeneity in Attention Deficit/Hyperactivity Disorder (ADHD) (2019) · cites this paper as Molina et al., 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“potential longer-term efficacy could be the real advantage of tDCS over stimulant medication where effects are discontinued with discontinued drug administration and where effects appear to even wane in long-term continuous administration (Molina et al., 2009), presumably due to brain adaptation to the drug (Fusar-Poli et al., 2012).”
From Cognitive Neuroscience of Attention Deficit Hyperactivity Disorder (ADHD) and Its Clinical Translation (2018) · cites this paper as Molina et al., 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Such delayed consolidation effects reinforce the notion that brain self-regulation via NF affects neuroplasticity and may hence have unique longer-term efficacy compared to stimulant medication which does not affect neuroplasticity and may even loose efficacy over time (Molina et al., 2009), due to potential brain adaptation (Fusar-Poli et al., 2012).”
From Cognitive Neuroscience of Attention Deficit Hyperactivity Disorder (ADHD) and Its Clinical Translation (2018) · cites this paper as Molina et al., 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As in the 2 previous guidelines, this recommendation is based on the evidence that for many individuals, ADHD causes symptoms and dysfunction over long periods of time, even into adulthood.”
From Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents (2019) · cites this paper as [13]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite this large difference in medication use, there were no appreciable between-group differences in long-term academic achievement in reading or mathematics (Molina et al., 2009).”
From The effect of stimulant medication on the learning of academic curricula in children with ADHD: A randomized crossover study. (2022) · cites this paper as Molina et al., 2009
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This is the first study of its kind, and results are consistent with other randomized evidence with less controlled designs (Molina et al., 2009; Tamm et al., 2017) in failing to support the expectation that taking stimulant medication during childhood will impact children with ADHD’s long-term academic achievement.”
From The effect of stimulant medication on the learning of academic curricula in children with ADHD: A randomized crossover study. (2022) · cites this paper as Molina et al., 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These studies have identified childhood risk factors associated with a more persistent course, including higher levels of symptoms, comorbid oppositional-defiant disorder (ODD), lower IQ, and family socioeconomic disadvantage.”
From Evaluation of the persistence, remission, and emergence of attention-deficit/hyperactivity disorder in young adulthood (2016) · cites this paper as [11]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“As individuals with ADHD enter adolescence, their overt hyperactive and impulsive symptoms tend to decline, whereas their inattentive symptoms tend to persist.13,14”
From Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents (2019) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“ADHD is a chronic condition; therefore, the PCC should manage children and adolescents with ADHD in the same manner that they would children and youth with special health care needs, following the principles of the chronic care model and the medical home (Table 5).”
From Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents (2019) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“Authors of longitudinal studies have found that ADHD treatments are frequently not maintained over time13 and impairments persist into adulthood.70”
From Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents (2019) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“We are aware of only two such studies (Molina et al., 2009; Tamm et al., 2017).”
From The effect of stimulant medication on the learning of academic curricula in children with ADHD: A randomized crossover study. (2022) · cites this paper as Molina et al., 2009
In the citing paper
“data suggest limited longer-term benefits of stimulant and behavioral interventions, even when applied intensively for both school-age and preschool children (Molina et al., 2009; Riddle et al., 2013).”
From Improving Outcomes for Youth with ADHD: A Conceptual Framework for Combined Neurocognitive and Skill-Based Treatment Approaches (2014) · cites this paper as Molina et al., 2009
In the citing paper
“This suggests that the relative benefits of childhood treatment with stimulant medication, compared with non-pharmacological treatmentsFimprovement in cognitive deficits as well as reductions in symptom severityFmay dissipate after a 2-to 3-year period, whether or not the medication component of treatment is continued or withdrawn (Molina et al, 2009;Swanson et al, 2008a, b).”
From Understanding the Effects of Stimulant Medications on Cognition in Individuals with Attention-Deficit Hyperactivity Disorder: A Decade of Progress (2011) · cites this paper as Molina et al, 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032
An inventory for measuring clinical anxiety: Psychometric properties.
Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.56.6.893 · Cited by 14,407
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771
Selective Cortical Undercutting As a Means of Modifying and Studying Frontal Lobe Function in Man
Scoville, W. B. (1949) · Journal of neurosurgery · doi:10.3171/jns.1949.6.1.0065 · Cited by 7,374
Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment
Barkley, R. A., & Poillion, M. J. (1994) · Behavioral Disorders · doi:10.1177/019874299401900205 · Cited by 4,635
SHAFFER, D., FISHER, P., LUCAS, C. P., DULCAN, M. K., & SCHWAB-STONE, M. E. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200001000-00014 · Cited by 3,505
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
Roberts, B. W., & DelVecchio, W. F. (2000) · Psychological Bulletin · doi:10.1037/0033-2909.126.1.3 · Cited by 3,241
Mendelson, G. (1995) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048679509064964 · Cited by 2,592
Flagged first, then by citations
2 of the 55 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 801–900 of 1,000
Sertçelik, S., Gündoğmuş, İ., Gündüz, A., Eroğlu, M. Z., Çipil, A., & Ergün, N. (2022) · Psychiatric Annals · doi:10.3928/00485713-20220125-02 · Cited by 4
Attention-Deficit Hyperactivity Disorder
Swanson, J. M., Rommelse, N. N. J., Cotton, J., Sonuga-Barke, E. J. S., Jensen, P. S., & Castellanos, F. X. (2022) · Springer eBooks · doi:10.1007/978-1-4614-6434-1_169-2 · Cited by 4
Self-citationHoumann, T., Kaalund-Brok, K., Clemmensen, L., Petersen, M. A., Plessen, K. J., Bilenberg, N., Verhulst, F. C., Jeppesen, P., INDICES, Rasmussen, H. B., et al. (2023) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-023-02158-z · Cited by 6
Hill, D. M., Sibley, M. H., Stein, M. A., & Leviyah, X. (2024) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2023.0042 · Cited by 4
Using the 12-Steps as a Parenting Intervention With ADHD Adolescents
Grogan, M., & Weitzman, J. (2015) · American Journal of Family Therapy · doi:10.1080/01926187.2015.1051904 · Cited by 2
Alexander, B., Lizeth, H., Huibert, D. M., & Linkenkaer‐Hansen, K. (2012) · InTech eBooks · doi:10.5772/24885 · Cited by 4
Evaluation of Neurofeedback on ADHD Using Mobile Health Technologies
Pandria, N., Spachos, D., & Bamidis, P. D. (2016) · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · doi:10.1007/978-3-319-32703-7_247 · Cited by 3
Attention-deficit/hyperactivity disorder
Schweitzer, J. B., Fassbender, C., Lit, L., Reeves, G. M., & Powell, S. P. H. (2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52002-9.00022-x · Cited by 4
Therapeutic Video Games for Attention Deficit Hyperactivity Disorder (ADHD).
Tiitto, M. V., & Lodder, R. A. (2017) · PubMed · Cited by 4
Panei, P., & Arcieri, R. (2013) · Recenti Progressi in Medicina · doi:10.1701/1295.14326 · Cited by 4
Attention Deficit Hyperactivity Disorder and Males in the Juvenile Justice System
Eme, R. F. (2012) · InTech eBooks · doi:10.5772/29018 · Cited by 4
ADHD Through Different Developmental Stages
Kumperščak, H. G. (2013) · InTech eBooks · doi:10.5772/53963 · Cited by 4
Protective vigilance: a parental strategy in caring for a child diagnosed with ADHD
Goodwillie, G. (2013) · Journal of Family Therapy · doi:10.1111/1467-6427.12010 · Cited by 4
ADHD psychopharmacology across the lifespan
Vitiello, B. (2009) · Current Attention Disorders Reports · doi:10.1007/s12618-009-0010-7 · Cited by 4
Self-citationArnold, L. E., Hodgkins, P., Caci, H. M., Kahle, J. S., & Young, S. (2016) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.140101 · Cited by 5
Self-citationPrinciples for managing attention deficit hyperactivity disorder
Tonge, B. J. (2013) · Australian Prescriber · doi:10.18773/austprescr.2013.064 · Cited by 4
Transition in ADHD: attention to the lifespan
Poulton, A. S. (2016) · Australasian Psychiatry · doi:10.1177/1039856216671665 · Cited by 4
Hennig, T., Schramm, S. A., Linderkamp, F., & Koglin, U. (2016) · Journal of Cognitive Education and Psychology · doi:10.1891/1945-8959.15.3.412 · Cited by 4
Wesemann, D., & Cleve, S. N. V. (2018) · The Nurse Practitioner · doi:10.1097/01.npr.0000530307.76316.cf · Cited by 4
Attention deficit hyperactivity disorder (ADHD)
Kohn, M. R., & Griffiths, K. R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818872-9.00016-9 · Cited by 5
Neurodevelopmental Disorders: Attention‐Deficit/Hyperactivity Disorder
Newcorn, J. H., Leikauf, J. E., Johnson, B., Krone, B., & Halperin, J. M. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch45 · Cited by 4
Self-citationIs there potential for the treatment of children with ADHD beyond psychostimulants?
Hoekstra, P. J. (2011) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-011-0212-2 · Cited by 4
Attention‐Deficit/Hyperactivity Disorder
Newcorn, J. H., Powers, L., & McAllister, S. (2016) · doi:10.1002/9781118654231.ch28 · Cited by 4
Self-citationADHD, a Food-Induced Hypersensitivity Syndrome: in Quest of a Cause.
Pelsser, L. M. J. (2011) · Socio-Environmental Systems Modeling · Cited by 4
Goodman, D. W., Mago, R., Citrome, L., Swartz, H. A., McIntyre, R. S., Freeman, M. P., Clayton, A. H., Kasper, S. F., Vieta, E., Williams, A. R., et al. (2026) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2026.112863 · Cited by 3
Effects of a Primary Care-Based Engagement Intervention for Improving Use of ADHD Treatments
Waxmonsky, J. G., Waschbusch, D. A., Groff, D., Jairath, B., Sekhar, D. L., Sibley, M. H., Logan, J. M., & Fogel, B. N. (2023) · Journal of Pediatric Health Care · doi:10.1016/j.pedhc.2023.04.013 · Cited by 3
Medicalizando crianças e adolescentes
Freitas, F., & de Azevedo, L. J. C. (2022) · Estudos de Sociologia · doi:10.52780/res.v27iesp.2.16590 · Cited by 3
Gilbert, D. L., Crocetti, D., Horn, P. S., Wu, S. W., Huddleston, D. A., Ehrman, J. M., Migneault, K. Y., & Mostofsky, S. H. (2025) · Annals of the Child Neurology Society · doi:10.1002/cns3.20101 · Cited by 3
Kolari, T. A., Vuori, M. A., Rättö, H., Varimo, E. A., Aronen, E. T., Auranen, K. J., Saastamoinen, L., & Ruokoniemi, P. T. (2025) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-025-02735-4 · Cited by 4
EEG‑biofeedback (neurobiofeedback) a kompleksowe leczenie ADHD
Kołakowski, A. (2012) · Psychiatria i Psychologia Kliniczna · Cited by 3
“When the Prescription Pad Is Not Enough”
Radesky, J. S., Reddy, A., Steiner, N. J., & Augustyn, M. C. (2013) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e3182825ab1 · Cited by 3
DeBonis, D. A. (2010) · Cited by 2
Support Healthy Brain Development: Implications for Attention Deficit/ Hyperactivity Disorder 1, 2
Peper, E. (2014) · Cited by 3
Drug treatment of ADHD – tenuous scientific basis
Vogt, H., & Lunde, C. (2018) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.17.0917 · Cited by 3
Algorta, G. P., MacPherson, H. A., Arnold, L. E., Hinshaw, S. P., Hechtman, L. T., Sibley, M. H., & Owens, E. B. (2019) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-019-01460-z · Cited by 5
Self-citationWhy Are Long-term Benefits of Stimulant Medication So Difficult to Detect?
Molina, B. S. G., & Swanson, J. M. (2020) · The ADHD Report · doi:10.1521/adhd.2020.28.1.1 · Cited by 3
Self-citationKılınçel, Ş. (2020) · Sakarya Medical Journal · doi:10.31832/smj.777420 · Cited by 3
Niitsu, T., Oda, Y., Idemoto, K., Ota, K., Liu, J., Sasaki, T. G., Nakazato, M., Hashimoto, K., & Iyo, M. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113674 · Cited by 3
Fatores de risco ambientais para o transtorno de déficit de atenção e hiperatividade
Oliveira, J. A., Muniz, R. B., & de Moura, L. E. G. (2023) · Revista de Medicina · doi:10.11606/issn.1679-9836.v102i4e-166097 · Cited by 3
Young, J. L., Powell, R. N., Powell, A., Welling, L. L. M., Granata, L. E., Saal, J., & Nash, M. (2025) · BMC Psychiatry · doi:10.1186/s12888-024-06446-z · Cited by 7
Amado, L., Fernández, S. J., & Ceccato, R. (2016) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2016.08.004 · Cited by 3
Attention-Deficit/Hyperactivity Disorder
Barnes, A. J., & Borowsky, I. W. (2021) · American Academy of PediatricsItasca, IL eBooks · doi:10.1542/9781610023733-133 · Cited by 3
Teicher, M. H., Bolger, E. A., Hafezi, P., Garcia, L. C. H., McGreenery, C. E., Weiser, L. P., Ohashi, K., & Khan, A. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114973 · Cited by 3
Enduring Effects of Neurofeedback in Children
Coben, R., Arns, M., & Kouijzer, M. E. J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-382235-2.00015-9 · Cited by 3
Moghanloo, M., Aguilar‐Vafaie, M. E., Rostami, R., & Farahani, H. (2014) · NeuroRegulation · doi:10.15540/nr.1.2.131 · Cited by 2
Les médicaments de l'attention : les doutes d'un praticien
Falissard, B. (2014) · Esprit · doi:10.3917/espri.1401.0034 · Cited by 3
Transactional Experiences of Existential Anxiety as a Barrier to Effective Humanistic Intervention
Hunter, N., & Barsky, T. V. (2016) · Journal of Humanistic Psychology · doi:10.1177/0022167816646671 · Cited by 3
Diagnosing and Treating Developmental Disorders with qEEG and Neurotherapy
Bailey, T. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-396988-0.00013-1 · Cited by 3
Lee, E. K., Kim, H. S., & Yoo, H. K. (2017) · Journal of korean Academy of Child and Adolescent Psychiatry · doi:10.5765/jkacap.2017.28.2.115 · Cited by 3
Controversial treatments in psychiatry
Luty, J. S. (2017) · BJPsych Advances · doi:10.1192/apt.bp.115.014803 · Cited by 3
Attention-Deficit/Hyperactivity Disorder: An Overview
Stubbe, D. E. (2016) · Psychiatric Annals · doi:10.3928/00485713-20151203-01 · Cited by 3
«At arbejde systemisk i et diagnostisk felt» – revisited
Nielsen, J., & Hertz, S. (2014) · Fokus på familien · doi:10.18261/issn0807-7487-2014-01-04 · Cited by 3
Beau‐Lejdstrom, R., & ZITO, J. M. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1137 · Cited by 3
Paying Attention to Attention-Deficit/Hyperactivity Disorder
Dickstein, D. P. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.1504 · Cited by 3
Eckernäs, D., Hieronymus, F., Carlsson, T., & Bergquist, F. (2018) · IBRO Reports · doi:10.1016/j.ibror.2018.11.007 · Cited by 3
Pharmacotherapy for attention-deficit/hyperactivity disorder
Kim, B. (2019) · Journal of Korean Medical Association · doi:10.5124/jkma.2019.62.1.49 · Cited by 5
Gluten-Free Diet for the Treatment of ADHD; Pilot Study
Canal, L. A., Sáez, I. C., del Castillo, M. C. F., Antón, J. A., Vicente, I. D. P., Zaragozá, C. I., Gallego, J. T., & Martínez-Gómez, M. J. (2019) · OBM Neurobiology · doi:10.21926/obm.neurobiol.1902024 · Cited by 3
Stimulants: Definition, Pharmacology, Indications, Side Effects, and Treatment Strategies
Steinbuchel, P. H., & Greenhill, L. L. (2020) · Springer eBooks · doi:10.1007/978-3-319-56015-1_324-1 · Cited by 4
Self-citationOwens, J. S., Hustus, C. L., Everly, E. L., Evans, S. W., & Margherio, S. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818697-8.00029-7 · Cited by 3
Thompson, K. C., & Morris, R. J. (2016) · Advancing responsible adolescent development · doi:10.1007/978-3-319-29343-1_12 · Cited by 4
Neurological Mechanisms of Diagnosis and Therapy in School Children with ADHD in Poland
Nermend, M., Flaga-Gieruszyńska, K., Kroplewski, Z., & Nermend, K. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19137615 · Cited by 3
Sfrisi, S. J., Deemer, S. A., Tamakloe, D., & Edeh, O. M. (2017) · Cited by 3
Methylphenidate use in children with attention deficit hyperactivity disorder
Machado, F. S. N., Caetano, S. C., Hounie, A. G., Scivoletto, S., Muszkat, M., Gianfaldoni, I., Casella, E. B., de Andrade, Ê. R., Polanczyk, G. V., & do Rosário, M. C. (2015) · Revista de Saúde Pública · doi:10.1590/s0034-8910.2015049005966 · Cited by 3
Attention Deficit Hyperactivity Disorder (ADHD)
Binder, M. D., Hirokawa, N., & Windhorst, U. (2008) · Springer eBooks · doi:10.1007/978-3-540-29678-2_417 · Cited by 3
Epistemological and ethical aspects of time in scientific research
Jadreškić, D. (2020) · Institutional Repository of Leibniz Universität Hannover (Leibniz Universität Hannover) · doi:10.15488/10248 · Cited by 3
Verhaltenstherapie und psychopharmakologische Behandlung
Steinhausen, H. (2018) · Springer eBooks · doi:10.1007/978-3-662-57369-3_51 · Cited by 2
Children’s Preferences for Mental Health Service Options that Include Exercise: A Pilot Study
Wymbs, F. A., Smith, C., DeShazer, M., & Tensmeyer, M. (2023) · Journal of Child and Family Studies · doi:10.1007/s10826-023-02658-1 · Cited by 4
Neurodevelopmental Disorders: Attention Deficit Hyperactivity Disorder (ADHD)
Newcorn, J. H., Krone, B., Coghill, D., & Halperin, J. M. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_64 · Cited by 2
Self-citationSchuck, S. E. B., Zeiler, C., Stehli, A., Steinhoff, L., Stokes, R. Y., Jeffrey, S. E., & Granger, D. A. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1476522 · Cited by 2
Gollier-Briant, F., Ollivier, L., Joalland, P.-H., Mouchabac, S., Leray, P., & Bonnot, O. (2024) · JMIR Research Protocols · doi:10.2196/44553 · Cited by 2
Mohammed, M. A. E. H., Haggag, W., AbdElhady, M. E., & Hendi, A. E. (2025) · Middle East Current Psychiatry · doi:10.1186/s43045-025-00539-5 · Cited by 2
Liang, X., Wei, X., Huang, Y. Q., Li, J., Feng, H., Fan, J., Zhang, L., Wang, Z., Zhao, X., Pan, W., et al. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1650154 · Cited by 4
Kim, J. W., Kim, B.-N., Kim, J. I., Yang, C.-M., & Kwon, J. (2025) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s554756 · Cited by 2
Advances in the management of ADHD in children and adolescents
Robaey, P., Rogers, M., & Schachar, R. J. (2026) · BMJ · doi:10.1136/bmj-2024-082507 · Cited by 2
Bloch, M. H., Gorman, D. A., & Abi‐Jaoude, E. (2012) · Evidence-Based Child Health A Cochrane Review Journal · doi:10.1002/ebch.1862 · Cited by 3
The Frontiers of Research About Attention-Deficit/Hyperactivity Disorder
Wolraich, M. (2015) · Pediatrics · doi:10.1542/peds.2015-0070 · Cited by 2
James, J. E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-802812-4.00015-1 · Cited by 3
Ayaz, A. B., Ayaz, M., Gökçe, S., & Başgül, Ş. S. (2016) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2016.1166513 · Cited by 1
The effects of drug safety warnings on drug sales and share prices
Bialkowski, J. P., & Clark, J. (2021) · Health Economics · doi:10.1002/hec.4440 · Cited by 2
Stimulants: Definition, Pharmacology, Indications, Side Effects, and Treatment Strategies
Steinbuchel, P. H., & Greenhill, L. L. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_324 · Cited by 3
Self-citationSantos, C. P. R. D., Júnior, J. R. B. D. S., Campos, D. M., Hoyer, E. R., Mendonça, M. N., Neto, G. V. D. A., Rolim, R. T., Vieira, R. E. G., Terror, M. T. S., Rezende, K. M. C. D., et al. (2023) · Brazilian Journal of Health Review · doi:10.34119/bjhrv6n3-177 · Cited by 2
Bilgili-Karabacak, I., Hand, S. L., Settanni, E., Ivory, K. P., Chen, R., Kern, L., Evans, S. W., Aregood, E. K., & Dever, B. V. (2023) · School Mental Health · doi:10.1007/s12310-023-09592-z · Cited by 2
Redmond, S. M., Ash, A. C., & Zhang, Y. (2023) · Clinical Linguistics & Phonetics · doi:10.1080/02699206.2023.2273750 · Cited by 2
Is prevention of ADHD and comorbid conditions in adolescents possible?
Vitiello, B., Davico, C., & Döpfner, M. (2023) · Journal of Attention Disorders · doi:10.1177/10870547231211596 · Cited by 2
Self-citationBui, H. N. T., Marsh, N. P., & Chronis-Tuscano, A. M. (2024) · Nature Mental Health · doi:10.1038/s44220-024-00234-0 · Cited by 3
Impactos do TDAH à Adolescência: Revisão Sistemática de Literatura
Pires, S. M. A. M., Pontes, F. A. R., Pereira, B. L. D. S., Amoras, J. D. F., & Silva, S. S. D. C. (2024) · Revista Brasileira de Educação Especial · doi:10.1590/1980-54702024v30e0174 · Cited by 10
Novel and complementary treatment approaches in attention-deficit/hyperactivity disorder
Caterfino, A., Krishna, S., & Chen, V. (2024) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000001378 · Cited by 2
Reduced Efficacy of Behavior Therapy Following Initial Multimodal Treatment of ADHD
Ramos, M. C., Piscitello, J., Robertson, E., Altszuler, A. R., Merrill, B. M., Macphee, F. L., Gnagy, E. M., Greiner, A. R., Pelham, W. E., Swanson, J. M., et al. (2024) · Evidence-Based Practice in Child and Adolescent Mental Health · doi:10.1080/23794925.2024.2384092 · Cited by 3
Self-citationSibley, M. H., Rodriguez, L. M., Lopez, M., Brochu, E. M., Bracho, F. V., Ortiz, M., & Hashimoto, J. (2025) · Journal of Attention Disorders · doi:10.1177/10870547241308632 · Cited by 2
A Pilot Study of a Device and Drug Therapy for ADHD.
Tiitto, M. V., Smith, R. R., Banfield, A., Ensor, M., & Lodder, R. A. (2017) · PubMed · Cited by 2
Attention-Deficit Hyperactivity Disorder
Swanson, J. M., Rommelse, N. N. J., Cotton, J., Sonuga-Barke, E. J. S., Jensen, P. S., & Castellanos, F. X. (2022) · Springer eBooks · doi:10.1007/978-3-030-88832-9_169 · Cited by 2
Self-citationEme, R. F., & Mouritson, J. (2013) · Cited by 2
Pigott, H. E., Bodenhamer-Davis, E., Davis, R. E., & Harbin, H. T. (2013) · Journal of Neurotherapy · doi:10.1080/10874208.2013.785178 · Cited by 2
Pigott, H. E., & Cannon, R. L. (2014) · NeuroRegulation · doi:10.15540/nr.1.1.25 · Cited by 1
Attention-deficit hyperactivity disorder: preventing overdiagnosis and overtreatment
St-Onge, J.-C. (2015) · Revista Brasileira de Medicina de Família e Comunidade · doi:10.5712/rbmfc10(35)1014 · Cited by 2
Schultz, B. K., & Evans, S. W. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2677-0_2 · Cited by 2
Multiple Origins of Sex Differences in Attention Deficit Hyperactivity Disorder
Swanson, J. M., Lakes, K. D., Wigal, T. L., & Volkow, N. D. (2012) · Research and perspectives in endocrine interactions · doi:10.1007/978-3-642-33721-5_8 · Cited by 2
Self-citationAdolescent Perceptions of Outgrowing Childhood Attention-Deficit Hyperactivity Disorder
Anixt, J. S., Vaughn, A. J., Powe, N. R., & Lipkin, P. H. (2016) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000000279 · Cited by 3
Update on Long-term Stimulant Medication Treatment of Attention-Deficit Hyperactivity Disorder
Barbaresi, W. J. (2014) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000000084 · Cited by 2
Metadata
- Authors
- Molina, B. S. G., Hinshaw, S. P., Swanson, J. M., Arnold, L. E., Vitiello, B., Jensen, P. S., Epstein, J. N., Hoza, B., Hechtman, L., Abikoff, H. B., Elliott, G. R., Greenhill, L. L., Newcorn, J. H., Wells, K. C., Wigal, T., Gibbons, R. D., Hur, K., & Houck, P. R.
- Affiliations
- University of Pittsburgh (US)
- University of California, Berkeley (US)
- University of California, Irvine (US)
- National Institute of Mental Health (US)
- Duke University (US)
- Long Island Jewish Medical Center (US)
- New York State Psychiatric Institute (US)
- University of Illinois Chicago (US)
- Corresponding author
- Molina, Brooke S.G.
- ORCID
- Venue
- Journal of the American Academy of Child & Adolescent Psychiatry
- Publisher
- Elsevier BV
- Published
- 2009-05
- Volume
- 48
- Issue
- 5
- Pages
- 484-500
- ISSN
- 0890-8567 (ISSN-L)
- PMC
- PMC3063150
- OpenAlex
- W2144385879
- Cited by
- 1,182
- References
- 55
- Citations by year
- 2026: 24 · 2025: 41 · 2024: 37 · 2023: 39 · 2022: 53 · 2021: 44 · 2020: 69 · 2019: 79 · 2018: 59 · 2017: 85 · 2016: 108 · 2015: 92 · 2014: 109 · 2013: 76 · 2012: 94
- FWCI
- 53.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of the American Academy of Child & Adolescent Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Funders
- U.S. Department of Health and Human Services
- U.S. Department of Justice
- U.S. Department of Education
- Abbott Laboratories
- Eli Lilly and Company
- Pfizer
- Sanofi
- Purdue University
- Celgene
- University of Pittsburgh (HHSN271200800008-C, U01 MH50467, N01MH 12010)
- McGill University (N01MH12008, HHSN271200800003-C)
- Purdue Pharma
- York University
- National Institutes of Health (n01mh12011-0-0-1, n01mh012009-007, n01mh12008-0-0-1, n01mh12010-0-0-1, n01mh12004-0-0-0, n01mh12007-0-0-0, n01mh012012-001)
- Medical Center, University of Pittsburgh
- University of California, Irvine (HHSN271200800006-C, N01MH 12004)
- National Institute of Mental Health (U01MH50461, N01 MH12007, N01MH-12012, N01 MH012007, U01MH50440, N01MH12008,, U01MH050467, MH-50467, N01 MH012009, U01 MH50477, N01 MH012011, U01MH050447, U01MH050440, N01 MH012012, N01 MH12009, U01MH050453, N01 MH012010, U01MH50467, U01MH050461, N01MH 12004, U01MH50453, N01MH 12010, U01MH050454, N01 MH012004, N01 MH012008)
- National Institute on Drug Abuse (HHSN271200800003C, HHSN271200800006C, N01 DA085550, N01 DA085552, HHSN271200800008C, N01 DA085549, HHSN271200800005C, N01 DA085551, N01 DA085548, HHSN271200800007C, HHSN271200800009C, N01 DA085553, N01 DA085554, R01DA012414, HHSN271200800004C)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
- Keywords
- attention deficit hyperactivity disorder, combined type ADHD, long-term outcomes, symptom trajectories, prognostic factors, treatment effects, medication use, adolescent functioning, academic performance, arrests, psychiatric hospitalization
- MeSH terms
- Adolescent, Attention Deficit Disorder with Hyperactivity, Behavior Therapy, Behavioral Symptoms, Child, Combined Modality Therapy, Community Mental Health Services, Female, Follow-Up Studies, Humans, Male, Psychiatric Status Rating Scales, Psychotropic Drugs, Reference Values, Regression Analysis, Case-Control Studies, Treatment Outcome, Attention Deficit and Disruptive Behavior Disorders, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
